Article

Weekly Webinar Series Part 6: Managing Lung Cancer Patients Through the COVID-19 Pandemic

Author(s):

In part 6 of our weekly COVID-19 Webinar Series, our panel of experts will share the latest updates and insights on the novel coronavirus. Join us Wednesday, April 29, 2020 at 8 PM EST.

Date/Time: Wednesday, April 29, 2020 at 8 PM EDT

In part 6 of our weekly COVID-19 Webinar Series, Nathan Pennell, MD, PhD; Stephen Liu, MD; Charu Aggarwal, MD, MPH; H. Jack West, MD: and special guest speaker, Brendon Stiles, MD; will share the latest updates and insights on the novel coronavirus.

Click here to register today!

Speakers:

Associate Professor; Director, Lung Cancer, Medical Oncology Program at Cleveland Clinic, Cleveland, Ohio

Associate Professor of Medicine; Director, Thoracic Oncology at Georgetown University, Washington, DC

Leslye M. Heisler Assistant; Professor of Medicine at University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania

Associate Clinical Professor in Medical Oncology; Executive Director, Employer Services at City of Hope Comprehensive Cancer Center, Irwindale, CA

Brendon Stiles, MD, Special Guest Speaker; Associate Professor of Cardiothoracic Surgery, Weill Cornell Medical College and Associate Attending Cardiothoracic Surgeon at NewYork-Presbyterian Hospital

Related Videos
Steven H. Lin, MD, PhD
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the next steps for biomarker testing in NSCLC.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on tissue and liquid biopsies for biomarker testing in NSCLC.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on the benefits of in-house biomarker testing in NSCLC.
Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, on treatment planning after biomarker testing in NSCLC.